Xiao-Jiang Li

Prof. Xiao-Jiang Li

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HThuichun Tong
huichun Tong
TYTianqi Yang
Tianqi Yang
SXShuying Xu
Shuying Xu
XLXinhui Li
Xinhui Li
LLLi Liu
Li Liu
SLShihua Li
Shihua Li
Huntington’s disease (HD) arises from the abnormal expansion of CAG repeats in the huntingtin gene (HTT), resulting in the production of the mutant huntingtin protein (mHTT) with a polyglutamine stretch in its N-terminus. The pathogenic mechanisms underlying HD are complex and not yet fully elucidated. However, mHTT forms aggregates and accumulates abnormally in neuronal nuclei and processes, leading to disruptions in multiple cellular functions. Although there is currently no effective curative treatment for HD, significant progress has been made in developing various therapeutic strategies to treat HD. In addition to drugs targeting the neuronal toxicity of mHTT, gene therapy approaches that aim to reduce the expression of the mutant HTT gene hold great promise for effective HD therapy. This review provides an overview of current HD treatments, discusses different therapeutic strategies, and aims to facilitate future therapeutic advancements in the field.

22 December 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
QJQingqing Jia
Qingqing Jia
SLShihua Li
Shihua Li
XLXiao-Jiang Li
Xiao-Jiang Li
PYPeng Yin
Peng Yin
Huntington’s disease (HD) is a progressive neurodegenerative disease characterized by preferential loss of neurons in the striatum in patients, which leads to motor and cognitive impairments and death that often occurs 10-15 years after the onset of symptoms. The expansion of a glutamine repeat (>36 glutamines) in the N-terminal region of huntingtin (HTT) has been defined as the cause of HD, but the mechanism underlying neuronal death remains unclear. Multiple mechanisms, including inflammation, may jointly contribute to HD pathogenesis. Altered inflammation response is evident even before the onset of classical symptoms of HD. In this review, we summarize the current evidence on immune and inflammatory changes, from HD animal models to clinical phenomenon of patients with HD. The understanding of the impact of inflammation on HD would help develop novel strategies to treat HD.

22 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
HYHuiming Yang
Huiming Yang
SYSu Yang
Su Yang
LJLiang Jing
Liang Jing
LHLuoxiu Huang
Luoxiu Huang
LCLuxiao Chen
Luxiao Chen
XLXiao-Jiang Li
Xiao-Jiang Li
Polyglutamine expansion in proteins can cause selective neurodegeneration, although the mechanisms are not fully understood. In Huntington’s disease (HD), proteolytic processing generates toxic N-terminal huntingtin (HTT) fragments that preferentially kill striatal neurons. Here, using CRISPR/Cas9 to truncate full-length mutant HTT in HD140Q knock-in (KI) mice, we show that exon 1 HTT is stably present in the brain, regardless of truncation sites in full-length HTT. This N-terminal HTT leads to similar HD-like phenotypes and age-dependent HTT accumulation in the striatum in different KI mice. We find that exon 1 HTT is constantly generated but its selective accumulation in the striatum is associated with the age-dependent expression of striatum-enriched HspBP1, a chaperone inhibitory protein. Our findings suggest that tissue-specific chaperone function contributes to the selective neuropathology in HD, and highlight the therapeutic potential in blocking generation of exon 1 HTT.

16 February 2023 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
SYSen Yan
Sen Yan
XZXiao Zheng
Xiao Zheng
YLYingqi Lin
Yingqi Lin
CLCaijuan Li
Caijuan Li
ZLZhaoming Liu
Zhaoming Liu
SLShihua Li
Shihua Li

21 April 2016 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
TZTing Zhao
Ting Zhao
YHYan Hong
Yan Hong
XLXiao-Jiang Li
Xiao-Jiang Li
SLShihua Li
Shihua Li
Huntington’s disease (HD) is an autosomal dominant, progressive neurodegenerative disease caused by an expanded polyglutamine (polyQ) tract in the N-terminal region of mutant huntingtin (mHtt). As a result, mHtt forms aggregates that are abundant in the nuclei and processes of neuronal cells. Although the roles of mHtt aggregates are still debated, the formation of aggregates points to deficient clearance of mHtt in brain cells. Since the accumulation of mHtt is a prerequisite for its neurotoxicity, exploring the mechanisms for mHtt accumulation and clearance would advance our understanding of HD pathogenesis and help us develop treatments for HD. We know that the ubiquitin-proteasome system and autophagy play important roles in clearing mHtt; however, how mHtt preferentially accumulates in neuronal nuclei and processes remains unclear. Studying the clearance of mHtt in neuronal cells is a challenge because neurons are morphologically and functionally polarized, which means the turnover of mHtt may be distinct in different cellular compartments. In this review, we discuss our current knowledge about the clearance and accumulation of mHtt and strategies of examining mHtt clearance and accumulation in different subcellular regions

20 November 2021 in Protein & Cell
Verified
Journal Article
Open access
PDF file
WYWeili Yang
Weili Yang
XGXiangyu Guo
Xiangyu Guo
ZTZhuchi Tu
Zhuchi Tu
XCXiusheng Chen
Xiusheng Chen
RHRui Han
Rui Han
XLXiao-Jiang Li
Xiao-Jiang Li
In vitrostudies have established the prevalent theory that the mitochondrial kinase PINK1 protects neurodegeneration by removing damaged mitochondria in Parkinson’s disease (PD). However, difficulty in detecting endogenous PINK1 protein in rodent brains and cell lines has prevented the rigorous investigation of thein vivorole of PINK1. Here we report that PINK1 kinase form is selectively expressed in the human and monkey brains. CRISPR/Cas9-mediated deficiency of PINK1 causes similar neurodegeneration in the brains of fetal and adult monkeys as well as cultured monkey neurons without affecting mitochondrial protein expression and morphology. Importantly,PINK1mutations in the primate brain and human cells reduce protein phosphorylation that is important for neuronal function and survival. Our findings suggest that PINK1 kinase activity rather than its mitochondrial function is essential for the neuronal survival in the primate brains and that its kinase dysfunction could be involved in the pathogenesis of PD.